Nuance Investments LLC Acquires 2,100,583 Shares of Kenvue Inc. $KVUE

Nuance Investments LLC boosted its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 294.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,813,985 shares of the company’s stock after buying an additional 2,100,583 shares during the quarter. Kenvue makes up approximately 5.3% of Nuance Investments LLC’s investment portfolio, making the stock its 7th largest position. Nuance Investments LLC’s holdings in Kenvue were worth $48,541,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Cornerstone Planning Group LLC increased its position in Kenvue by 705.2% during the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after buying an additional 1,361 shares during the last quarter. Physician Wealth Advisors Inc. increased its position in Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after buying an additional 618 shares during the last quarter. Elyxium Wealth LLC acquired a new position in Kenvue during the fourth quarter worth approximately $26,000. SBI Securities Co. Ltd. increased its position in Kenvue by 82.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock worth $39,000 after buying an additional 1,027 shares during the last quarter. Finally, Atlantic Union Bankshares Corp increased its position in Kenvue by 184.1% during the third quarter. Atlantic Union Bankshares Corp now owns 2,619 shares of the company’s stock worth $43,000 after buying an additional 1,697 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on KVUE shares. Barclays reduced their price objective on Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Tuesday, April 14th. Argus upgraded Kenvue to a “hold” rating in a report on Friday, March 6th. Canaccord Genuity Group boosted their price objective on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. Citigroup reduced their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Finally, UBS Group reduced their price objective on Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a report on Tuesday, April 7th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $19.33.

Insider Activity

In related news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.59% of the company’s stock.

Kenvue Stock Up 4.9%

Shares of NYSE:KVUE opened at $17.72 on Friday. The company has a fifty day moving average of $17.37 and a 200-day moving average of $17.48. The company has a market capitalization of $34.01 billion, a PE ratio of 20.84, a price-to-earnings-growth ratio of 1.28 and a beta of 0.54. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $22.87.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.05. The company had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.24 earnings per share. On average, equities analysts predict that Kenvue Inc. will post 1.16 EPS for the current fiscal year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th were issued a dividend of $0.2075 per share. The ex-dividend date was Wednesday, May 13th. This represents a $0.83 annualized dividend and a dividend yield of 4.7%. Kenvue’s dividend payout ratio is 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.